These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8436104)

  • 21. Investigations on the mechanisms of methotrexate resistance in a cisplatin-resistant L1210 murine leukemia cell subline.
    Wroblewski DH; Bhushan A; Xuan Y; Brinton BT; Tritton TR; Hacker MP
    Cancer Chemother Pharmacol; 1996; 37(4):337-42. PubMed ID: 8548879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular glutathione heterogeneity in L1210 murine leukemia sublines made resistant to DNA-interacting anti-neoplastic agents.
    Tagliabue G; Pifferi A; Balconi G; Mascellani E; Geroni C; D'Incalci M; Ubezio P
    Int J Cancer; 1993 May; 54(3):435-42. PubMed ID: 8509218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA-protein cross-linking in L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
    Olinski R; Briggs RC
    Mol Biol Rep; 1991 May; 15(2):81-6. PubMed ID: 1749377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
    Kido Y; Khokhar AR; al-Baker S; Siddik ZH
    Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cisplatin resistance in a murine leukemia cell line associated with defect of apoptosis].
    Segal-Bendirdjian E; Jacquemin-Sablon A
    Bull Cancer; 1996 May; 83(5):371-8. PubMed ID: 8680089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of cis-diamminedichloroplatinum(II) with sensitive and resistant L1210 cell lines. Drug binding to nuclei and DNA.
    Foka M; Belehradek J; Paoletti J
    Biochem Pharmacol; 1988 Sep; 37(18):3467-72. PubMed ID: 3421997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxicity, cellular uptake and DNA binding of the novel trinuclear platinun complex BBR 3464 in sensitive and cisplatin resistant murine leukemia cells.
    Di Blasi P; Bernareggi A; Beggiolin G; Piazzoni L; Menta E; Formento ML
    Anticancer Res; 1998; 18(4C):3113-7. PubMed ID: 9713519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quenching of DNA:platinum(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum(II) in L1210 cells.
    Micetich K; Zwelling LA; Kohn KW
    Cancer Res; 1983 Aug; 43(8):3609-13. PubMed ID: 6683124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of various mRNA potentially involved in cisplatin resistance of murine leukemia L1210 cells.
    Sheibani N; Eastman A
    Cancer Lett; 1990 Jul; 52(3):179-85. PubMed ID: 1974166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells.
    Sorenson CM; Eastman A
    Cancer Res; 1988 Dec; 48(23):6703-7. PubMed ID: 3180081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotype.
    Kamath N; Grabowski D; Ford J; Ganapathi R
    Br J Cancer; 1993 Jun; 67(6):1203-8. PubMed ID: 8099806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
    Orr RM; O'Neill CF; Nicolson MC; Barnard CF; Murrer BA; Giandomenico CM; Vollano JF; Harrap KR
    Br J Cancer; 1994 Sep; 70(3):415-20. PubMed ID: 8080724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activity.
    Hofs HP; Wagener TD; de Valk-Bakker V; van Rennes H; Doesburg WH; Ottenheijm HC; de Grip WJ
    Anticancer Drugs; 1997 Apr; 8(4):349-57. PubMed ID: 9180388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-resistance to ionizing radiation in a murine leukemic cell line resistant to cis-dichlorodiammineplatinum(II): role of Ku autoantigen.
    Frit P; Canitrot Y; Muller C; Foray N; Calsou P; Marangoni E; Bourhis J; Salles B
    Mol Pharmacol; 1999 Jul; 56(1):141-6. PubMed ID: 10385694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross resistance studies with L1210 leukemia subline single and double resistant to cisplatin and iproplatin (CHIP).
    Hrubisko M; Ujházy V
    Neoplasma; 1990; 37(6):631-8. PubMed ID: 2274083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor activity and cross-resistance studies with Pt-ascorbato complexes.
    Hrubisko M; Balázová E; Kiss F; Kovácová J; Ujházy V
    Neoplasma; 1989; 36(6):651-7. PubMed ID: 2615869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amino acid membrane transport properties of L1210 cells resistant to cisplatin.
    Gross RB; Scanlon KJ
    Chemioterapia; 1986 Feb; 5(1):37-43. PubMed ID: 3955782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of mitochondrial dynamics in the antineoplastic activity of cisplatin in murine leukemia L1210 cells.
    Han XJ; Shi SL; Wei YF; Jiang LP; Guo MY; Wu HL; Wan YY
    Oncol Rep; 2017 Aug; 38(2):985-992. PubMed ID: 28677814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
    Yoshida M; Khokhar AR; Siddik ZH
    Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.